Difference between revisions of "Cholangiocarcinoma"
Jump to navigation
Jump to search
(+infobox) |
|||
| Line 9: | Line 9: | ||
| LMDDx = [[metastatic carcinoma]] - esp. luminal GI tract, [[hepatocellular carcinoma]] | | LMDDx = [[metastatic carcinoma]] - esp. luminal GI tract, [[hepatocellular carcinoma]] | ||
| Stains = | | Stains = | ||
| IHC = | | IHC = CK7 +ve, CK20 +ve/-ve, CK19 +ve, HepPar-1 -ve, AFP -ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
| Line 16: | Line 16: | ||
| Grossing = | | Grossing = | ||
| Site = bile ducts (including pancreas, [[liver]] - see ''[[liver neoplasms]]'') | | Site = bile ducts (including pancreas, [[liver]] - see ''[[liver neoplasms]]'') | ||
| Assdx = | | Assdx = liver flukes (Clonorchis sinensis, Opisthorchis viverrini), [[Caroli disease]], [[primary sclerosing cholangitis]] - esp. in [[ulcerative colitis]] | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = | | Clinicalhx = | ||